Monday, May 04, 2020 11:19:40 PM
You are missing an important factor that's of value to all longs. I'm saying this as a seasoned if not terribly successful trader, not as an apologist for LP as should be very obvious from all my other comments on this. That factor is the value of not having 10s of millions of warrants exercised and the stock sold into the open market into a rally. Nobody really knows what the TLD will be nor how the trading will go, nor the technical effect on the stock to not have it crushed (maybe) by a huge number of new shares getting dumped into the float.
Now, we don't know how many millions of warrants LP is agreeing to refrain from exercising - to have a great deal of value it has to be a huge number of warrants, e.g. 40M might be very influential on the price, 10M probably not much if any. It all depends on the number and the trading. This may sound to some like it's just made up nonsense, especially to those who don't follow technical trading. But if the number of shares is big enough I am certain that there is much to be gained by reducing the shares exercised for cash and then sold into the market.
Linda's Form-4 tried to give her credit for not exercising the new warrants and that's total bullshit as I have been mentioning. The value provided in this regard in exchange for value received in the warrants can obviously only be credited to warrants she owns other than the extended 29M.
I know something about trading and I also know the power of technical events like the fact that killing a rally with a huge dump of shares can have long term effects on the trading price. For sure there is a chance of TLD driving a breakout and there is also a chance of a stillborn rally even on good but not fantastic data. You can believe that Linda sold a large bag of garbage with her claim but this consideration is part of the value, though that is true if and only if the number of previously existing warrants she is restrained on large enough.
I'm leaning towards the 'this is total BS' way of thinking, myself but I just want to consider all the angles in absence of any further explanation coming from the company. I guess even if the above applies it's hard to expect that many longs will even really grasp the argument let alone accept it.
Now, we don't know how many millions of warrants LP is agreeing to refrain from exercising - to have a great deal of value it has to be a huge number of warrants, e.g. 40M might be very influential on the price, 10M probably not much if any. It all depends on the number and the trading. This may sound to some like it's just made up nonsense, especially to those who don't follow technical trading. But if the number of shares is big enough I am certain that there is much to be gained by reducing the shares exercised for cash and then sold into the market.
Linda's Form-4 tried to give her credit for not exercising the new warrants and that's total bullshit as I have been mentioning. The value provided in this regard in exchange for value received in the warrants can obviously only be credited to warrants she owns other than the extended 29M.
I know something about trading and I also know the power of technical events like the fact that killing a rally with a huge dump of shares can have long term effects on the trading price. For sure there is a chance of TLD driving a breakout and there is also a chance of a stillborn rally even on good but not fantastic data. You can believe that Linda sold a large bag of garbage with her claim but this consideration is part of the value, though that is true if and only if the number of previously existing warrants she is restrained on large enough.
I'm leaning towards the 'this is total BS' way of thinking, myself but I just want to consider all the angles in absence of any further explanation coming from the company. I guess even if the above applies it's hard to expect that many longs will even really grasp the argument let alone accept it.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
